Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
14.07
-0.13 (-0.92%)
Nov 4, 2024, 4:00 PM EST - Market closed

Rigel Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
248253259453591359
Upgrade
Market Cap Growth
-35.58%-2.48%-42.79%-23.38%64.89%-6.41%
Upgrade
Enterprise Value
301295269403560289
Upgrade
Last Close Price
14.2014.5015.0026.5035.0021.40
Upgrade
PE Ratio
--10.06-4.42-25.22-19.86-5.35
Upgrade
PS Ratio
1.912.182.243.275.446.05
Upgrade
PB Ratio
-4.82-8.83-19.0414.9217.386.67
Upgrade
P/FCF Ratio
-11.72-44.03-3.4986.30-11.07-8.35
Upgrade
P/OCF Ratio
-11.72-44.03-3.5177.10-11.33-8.64
Upgrade
EV/Sales Ratio
2.312.552.332.905.154.88
Upgrade
EV/EBITDA Ratio
-26.10-14.49-4.66-21.98-19.80-4.23
Upgrade
EV/EBIT Ratio
-21.52-13.66-4.59-20.67-19.32-4.19
Upgrade
EV/FCF Ratio
-15.94-51.34-3.6376.67-10.47-6.74
Upgrade
Debt / Equity Ratio
-3.35-3.64-6.443.001.150.67
Upgrade
Debt / FCF Ratio
-8.15-18.14-1.1817.38-0.73-0.85
Upgrade
Asset Turnover
1.060.920.771.000.840.41
Upgrade
Inventory Turnover
2.862.175.1710.8212.2120.50
Upgrade
Quick Ratio
1.331.641.512.211.791.86
Upgrade
Current Ratio
1.621.861.782.432.182.04
Upgrade
Return on Equity (ROE)
---699.05%-55.63%-67.72%-81.73%
Upgrade
Return on Assets (ROA)
-4.64%-10.73%-24.34%-8.77%-14.04%-30.13%
Upgrade
Return on Capital (ROIC)
-7.73%-18.03%-37.50%-12.50%-22.19%-43.18%
Upgrade
Earnings Yield
-5.70%-9.92%-22.59%-3.95%-5.03%-18.65%
Upgrade
FCF Yield
-4.93%-2.27%-28.62%1.16%-9.04%-11.98%
Upgrade
Buyback Yield / Dilution
-0.93%-0.93%-1.12%-1.03%-0.81%-4.28%
Upgrade
Total Shareholder Return
-0.93%-0.93%-1.12%-1.03%-0.81%-4.28%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.